调节痛风中的脂质代谢:具有治疗潜力的新视角
Xianheng Zhang1,2, Jian Liu1,3
1Department of Rheumatology and Immunology, First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui Province, 230031, People's Republic of China.
International journal of general medicine
|November 18, 2024
概括
痛风患者表现出脂肪代谢的改变,影响尿酸水平和炎症. 了解这些脂质变化为痛风管理提供了新的治疗策略.
科学领域:
- 代谢性疾病研究研究.
- 生物化学 生物化学
- 临床脂质学 临床脂质学
背景情况:
- 痛风是一种代谢性疾病,由于尿酸代谢异常导致炎症性关节炎.
- 痛风经常涉及心损伤和血管并发症.
- 脂质代谢和痛风之间的相互作用是越来越多的研究领域.
研究的目的:
- 审查痛风患者的脂质代谢变化.
- 探索脂质变化在痛风发展,尿酸代谢,炎症和并发症中的作用.
- 总结了在痛风中异常脂质代谢的管理策略.
主要方法:
- 对痛风中脂质代谢的系统性文献综述.
- 在PubMed和Web of Science进行的自2000年以来的研究搜索.
- 分析与脂管学和痛风病原性相关的发现.
主要成果:
- 在痛风患者中,临床检测到的血脂变化很常见.
- 脂管学揭示了特定的小脂分子变化和痛风中途径失调.
- 脂质代谢的变化与痛风风险,尿酸水平,炎症和相关疾病有关.
结论:
- 异常的脂质代谢是痛风发病的组成部分.
- 向脂质代谢为痛风提供了新的治疗途径.
- 综合管理策略包括药物,饮食和运动,用于痛风患者.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
538
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
538
Cholesterol: Significance and Regulation
510
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
510
Glucagon-like Receptor Agonists
300
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
300
GPCRs Regulate Adenylyl Cylase Activity
5.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.3K
Overview of Lipid Metabolism
1.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.0K
G Protein-coupled Receptors
11.4K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.4K


